{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:49:18Z","timestamp":1790686158633,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.healun.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T18:06:47Z","timestamp":1402942007000},"page":"16-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation"],"prefix":"10.1016","volume":"34","author":[{"given":"Allan R.","family":"Glanville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Aboyoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Treede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Boehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Benden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Corris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2014.06.001_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.healun.2013.08.007","article-title":"The Registry of the International Society for Hart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report\u20142013; focus theme: age","volume":"32","author":"Yusen","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.healun.2007.04.004","article-title":"Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome","volume":"26","author":"Burton","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/ajrccm.155.3.9117010","article-title":"Lung transplantation","volume":"155","author":"Trulock","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2014.06.001_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.healun.2003.07.003","article-title":"Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation","volume":"23","author":"Luckraz","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib5","first-page":"713","article-title":"A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation","volume":"12","author":"Cooper","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":"Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria","volume":"21","author":"Estenne","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200706-951OC","article-title":"Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation","volume":"177","author":"Glanville","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2014.06.001_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TP.0b013e3181852f02","article-title":"Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies","volume":"86","author":"Burton","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1053-2498(01)00405-3","article-title":"Respiratory viruses and chronic rejection in lung transplant recipients","volume":"21","author":"Billings","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","article-title":"Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death","volume":"170","author":"Khalifah","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2014.06.001_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1378\/chest.118.4.1214","article-title":"Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation","volume":"118","author":"Palmer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.healun.2014.06.001_bib12","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.transproceed.2010.05.155","article-title":"Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts","volume":"42","author":"Shah","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2014.06.001_bib13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.healun.2009.05.040","article-title":"Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective","volume":"28","author":"King","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/09031936.00064807","article-title":"Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection","volume":"31","author":"Blondeau","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2014.06.001_bib15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/thx.2011.159525","article-title":"Every breath you take","volume":"66","author":"Glanville","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2014.06.001_bib16","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1600-6143.2012.04134.x","article-title":"Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution","volume":"12","author":"Verleden","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.athoracsur.2006.03.070","article-title":"Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?","volume":"82","author":"Luckraz","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2014.06.001_bib18","first-page":"303","article-title":"Bronchiolitis obliterans: the Achilles heel of lung transplantation","volume":"64","author":"Frost","year":"2002","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"10.1016\/j.healun.2014.06.001_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1043-0679(98)70040-1","article-title":"Bronchiolitis obliterans","volume":"10","author":"Sundaresan","year":"1998","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2014.06.001_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2014.06.001_bib21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1517\/13543784.11.12.1845","article-title":"Review of the proliferation inhibitor everolimus","volume":"11","author":"Nashan","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.healun.2014.06.001_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.TP.0000101822.50960.AB","article-title":"Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation","volume":"77","author":"Azzola","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib24","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.02.00281602","article-title":"The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats","volume":"19","author":"Simler","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2014.06.001_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1053-2498(99)00118-7","article-title":"Prevention of small airway obliteration in a swine heterotopic lung allograft model","volume":"19","author":"Salminen","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2014.06.001_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ RAD, a new rapamycin derivative: synergism with cyclosporine","volume":"64","author":"Schuurman","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1053-2498(98)00020-5","article-title":"Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine","volume":"18","author":"Hausen","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00007890-199904150-00005","article-title":"Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment","volume":"67","author":"Hausen","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00007890-200001150-00015","article-title":"Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability","volume":"69","author":"Hausen","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","article-title":"Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study","volume":"31","author":"Potena","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.healun.2011.12.010","article-title":"Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate","volume":"31","author":"Arora","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1053-2498(02)01221-4","article-title":"Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure","volume":"22","author":"Kovarik","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib34","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1600-6143.2010.03129.x","article-title":"Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients","volume":"10","author":"Tedesco Silva","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","article-title":"Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies","volume":"4","author":"Vitko","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1046\/j.1600-6135.2003.00242.x","article-title":"Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patients","volume":"3","author":"Kovarik","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-6143.2005.01134.x","article-title":"Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial","volume":"6","author":"Snell","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib38","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.healun.2006.03.020","article-title":"Cyclosporine C2 target levels and acute cellular rejection after lung transplantation","volume":"25","author":"Glanville","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib39","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1002\/sim.5402","article-title":"Improving the reporting of randomised trials: the CONSORT Statement and beyond","volume":"31","author":"Altman","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.healun.2014.06.001_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2014.06.001_bib41","first-page":"1","article-title":"Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group","volume":"15","author":"Yousem","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib42","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib43","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.tp.0000202755.33883.61","article-title":"Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients","volume":"81","author":"McNeil","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.06.001_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.201005-0775OC","article-title":"Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation","volume":"183","author":"Bhorade","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2014.06.001_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.healun.2012.03.008","article-title":"Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation","volume":"31","author":"Treede","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.healun.2010.08.010","article-title":"Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation","volume":"30","author":"Ahya","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.thromres.2013.07.004","article-title":"Treatment with everolimus is associated with a procoagulant state","volume":"132","author":"Baas","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.healun.2014.06.001_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1053-2498(03)00309-7","article-title":"Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression","volume":"23","author":"Groetzner","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.06.001_bib49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/01.TP.0000064083.02120.2C","article-title":"Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation","volume":"75","author":"King-Biggs","year":"2003","journal-title":"Transplantation"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249814011553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249814011553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:28:17Z","timestamp":1760948897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249814011553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1053249814011553"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2014.06.001","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}